Virginia TB Intensive Workshop

CE Accredited Live Activity
Date: October 7-9, 2025
Location:
Training Room
ICPH, 1st Floor West Wing
225 Warren Street
Newark, NJ 07103

Jointly provided by Rutgers Global Tuberculosis Institute and Virginia Department of Health

COURSE DESCRIPTION & OVERALL GOAL
This workshop for clinicians provides comprehensive information on the application of principles for the diagnosis and treatment of TB, as well as the management of TB in special situations. The goal is to enhance healthcare provider knowledge and skills in the diagnosis, treatment, and management of TB, promote networking among providers and encourage providers to seek expert consult when needed. Topics include transmission and pathogenesis, testing for TB infection, treatment of TB infection, diagnosis and treatment of TB disease, drug resistance, TB-HIV co-infection, extrapulmonary TB, TB in children and adolescents, and key aspects of patient management. The format includes lectures, interactive discussions, and case studies.

AGENDA

WHO SHOULD ATTEND
The workshop is designed for physicians, nurses and healthcare professionals who are involved in the diagnosis and management of TB patients. Individuals who work in the following settings would benefit from attending this workshop:

  • TB Programs
  • Health Departments
  • Hospitals
  • Correctional Facilities
  • Long Term Care Facilities
  • Immigrant & Refugee Health
  • Community Health Centers / Federally Qualified Health Centers
  • College or University Health Services

WHY COURSE IS NEEDED
As the incidence of tuberculosis continues to decline, maintaining clinical and public health expertise in TB is particularly challenging. Therefore, ongoing training and education are important for healthcare providers to enhance skills in TB diagnosis, follow recommended treatment guidelines, and interact effectively with public health agencies. This type of training is also important for new clinicians working in TB control or other settings.

COURSE REQUIREMENTS
This course will build upon basic TB concepts. Prior to the course, it is recommended that participants review the CDC’s Core Curriculum on Tuberculosis: What the Clinician Should Know (Available at:https://www.cdc.gov/tb/hcp/education/core-curriculum-on-tuberculosis.html). In order to meet the learning objectives and receive continuing education credits, participants are required to attend the entire course, and complete an evaluation form. A post-course follow-up evaluation will be sent within 3 months of the course.

OBJECTIVES
Upon completion of this workshop, participants should be better able to:

  • Interpret epidemiologic trends to better screen and treat groups who are at high risk for tuberculosis.
  • Apply the latest advances for assessing risk, testing, and treating TB infection to prevent development of disease.
  • Implement recommendations for prompt diagnosis, appropriate treatment and effective management of tuberculosis disease.
  • List approaches for addressing clinical and social challenges in the management of patients with tuberculosis to achieve successful outcomes.

CONTINUING EDUCATION INFORMATION
Logo, company name  Description automatically generatedIn support of improving patient care, this activity has been planned and implemented by Rutgers Biomedical and Health Sciences and the Virginia Department of Health. Rutgers Biomedical and Health Sciences is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
CME: Rutgers Biomedical and Health Sciences designates this live activity for a maximum of 16.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity
CNE: This activity is awarded 16.0 ANCC contact hours. Nurses should only claim those contact hours actually spent participating in the activity.

DISCLOSURE DECLARATION
The relevant financial relationships of all individuals who affect the content of continuing education activities and any discussion of off-label/investigational uses will be disclosed to the audience at the time of the activity.

APPLICATION INFORMATION & FEE
Please note that the registration has been closed. If you would like to be on a waitlist, please reach out to Jane Tingley at Jane.Tingley@vdh.virginia.gov.

CANCELLATION AND REFUND INFORMATION
Please note that refunds will only be issued if registrants notify us of their cancellation by September 22. We will not be able to provide any refunds if registrants cancel after the deadline.
We reserve the right to modify the activity content, faculty and activities, and to cancel this activity, if necessary.

FUNDING DISCLOSURE
Funding for this course was made possible in part by the Centers for Disease Control and Prevention. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services, nor does the mention of trade names, commercial practices, or organizations imply endorsement by the U.S. government.

If you require an accommodation because of a disability, or if you have any additional needs or other questions, please contact Shwata Suresh Kumar at
ss2980@rutgers.edu.  

FACULTY

Jane Carter, MD
Emeritus Professor of Medicine
Brown University 

Saritha Gomadam , MD
Medical Director
Richmond Henrico Health District  

Eric Houpt, MD
Professor and Chief of the Division of Infectious Diseases and International Health
University of Virginia

Scott Heysell, MD, MPH
Professor of International Medicine
University of Virginia

Kathleen Milloy
Principal Scientist
Virginia State Public Health Laboratory

Rana Mehr, MS
Principal Scientist
Virginia State Public Health Laboratory

Tina Shah
Patient Advocate
We are TB  

Tania Thomas, MD, MPH
Associate Professor, Department of Medicine
Division of Infectious Diseases and International Health

University of Virginia

Shu-Hua Wang, MD
Professor of Medicine
The Ohio State University College of Medicine

Stephanie Wheawill, PharmD
Director, Division of Pharmacy Services
Virginia Department of Health

Laura Young, MPH, CIC
Tuberculosis Epidemiologist
Virginia Department of Health

 

 

PLANNING COMMITTEE

Amy Beahm, RN, BSN
TB Nurse Consultant
Virginia Department of Health

Saritha Gomadam , MD
Medical Director
Richmond Henrico Health Distric
t

Anita Khilall, MPH - Activity Director
Program Director, Education & Training
Rutgers Global Tuberculosis Institute

Adwoa Sam, RN
TB Nurse Consultant
Virginia Department of Health

Shwata Suresh Kumar, MPH
Training and Consultation Specialist
Rutgers Global Tuberculosis Institute

Jane Tingley, MPH
LTBI Projects and Engagement Coordinator
Virginia Department of Health

Laura Young, MPH, CIC
Tuberculosis Epidemiologist
Virginia Department of Health